Pat Roberts said...

One new requirement under the Cures Act is for manufacturers of an investigational drug to make its policies on evaluati...

the Tax Reform Bill is moving through committee. It's being amended this week, or amendments are being offered.

I want to talk for just a moment about applicant burden reduction.

The drug industry has spent more time finger pointing on who is responsible for high prices instead of taking action.